MASTER PURCHASE AGREEMENTMaster Purchase Agreement • August 6th, 2015 • Warner Chilcott LTD • Pharmaceutical preparations • New York
This Master Purchase Agreement (this “Agreement”), dated as of July 26, 2015, is entered into by and between Teva Pharmaceutical Industries Ltd., a company organized under the laws of Israel (“Buyer Parent”) and Allergan plc, a public company limited by shares organized under the laws of Ireland (“Seller Parent”). Seller Parent and the Controlled Affiliates of Seller Parent that are party to any Ancillary Agreement are referred to in this Agreement each as a “Seller” and collectively as “Sellers.” Sellers and Buyer Parent sometimes are referred to in this Agreement collectively as the “Parties” and individually as a “Party.”
Paul M. Bisaro c/o Actavis, Inc. Morris Corporate Center III 400 Interpace Parkway Parsippany, New Jersey 07054 Dear Mr. Bisaro: Actavis, Inc., a Nevada corporation (the “Company”) and a wholly‑owned subsidiary of Allergan plc, an Irish public limited...Warner Chilcott LTD • August 6th, 2015 • Pharmaceutical preparations • New Jersey
This Agreement supersedes the Amended and Restated Employment Agreement entered into by and between Watson Pharmaceuticals, Inc. and yourself on November 12, 2012 (the “Prior Agreement”) and the 2014 Agreement, both of which shall no longer be effective by mutual consent of the Company and yourself. Notwithstanding the preceding sentence, any equity‑based awards granted to you while the Prior Agreement was in effect shall continue to vest in accordance with their respective award agreements. The retention bonuses granted to you on November 7, 2013 shall also continue to vest pursuant to the terms contained in the retention bonus offer, and are unaffected by this Agreement.
